Skip to content

Predictive value of height shortening on brachiocephalic tortuosity in patients undergoing coronary intervention

Predictive value of height shortening on b brachiocephalic tortuosity in patients undergoing coronary intervention

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045031
Enrollment
Unknown
Registered
2021-04-03
Start date
2021-04-06
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

brachiocephalic tortuosity group vs. non tortuosity group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing coronary angiography (percutaneous coronary intervention (PCI)) in Shanghai General Hospital from April 6, 2021 to December 31, 2021.

Exclusion criteria

Exclusion criteria: 1.Patients with rheumatic diseases affecting arterial development and stable structure include polyarteritis (Takayasu arteritis), Behcet's disease, mucocutaneous lymph node syndrome (Kawasaki disease), giant cell arteritis, such as ankylosing spondylitis, Wright's syndrome, nodular polyarteritis, and patients with arterial lesions caused by infection (syphilitic arteritis, etc.); 2.Patients who can't improve their height when they are young; 3.Patients who have undergone orthopedic surgery (amputation due to lumbar, thoracic, cervical diseases, femoral neck fracture, diabetes, etc.); 4.Patients who received surgery due to arterial trauma (from brachiocephalic artery to aorta).

Design outcomes

Primary

MeasureTime frame
Degree of height reduction;

Countries

China

Contacts

Public ContactCai Lidong

Shanghai General Hospital

1015651169@qq.com+86 18721383320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026